Dantrolene sodium treatment of amisulpride-related neuroleptic malignant syndrome:a case report
10.12173/j.issn.1005-0698.202312087
- VernacularTitle:丹曲林钠治疗氨磺必利相关恶性综合征1例
- Author:
Shumei WU
1
;
Yuxia SHI
;
Li ZHOU
Author Information
1. 四川大学华西医院麻醉手术中心(成都 610041);四川大学华西护理学院(成都 610041)
- Keywords:
Neuroleptic malignant syndrome;
Amisulpride;
Dantrolene sodium
- From:
Chinese Journal of Pharmacoepidemiology
2024;33(5):572-577
- CountryChina
- Language:Chinese
-
Abstract:
A 32-year-old woman,previously diagnosed with schizophrenia and undergoing long-term treatment with clozapine,experienced the onset of symptoms such as shallow coma,persistent high fever,and increased muscle tone one day after transitioning from clozapine to amisulpride.Combining with elevated creatine kinase levels and other examination findings,the patient was diagnosed with amisulpride-related neuroleptic malignant syndrome(NMS).Amisulpride treatment was promptly discontinued,and the patient was treated with bromocriptine,but it failed to relieve the symptoms.On the same day,intravenous administration of dantrolene sodium was conducted,then her body temperature decreased,convulsions and tremors improved,and other symptoms gradually relieved.After 5 days,her consciousness improved,and she was discharged after 10 days.Amisulpride-related NMS are relatively rare,and dantrolene sodium can be used as a potential option when conventional treatments prove ineffective.
